TNBC patients with small residual tumor size (≤2 cm) after NAC comprised 59/101 (58 %) and had significantly higher CD8+ TIL levels than patients with residual tumors larger than 2 cm (P=0.005). This evidence concerns the gene CD8A and neoplasm.